Notice of Change to Application Receipt Dates and Clarification of Eligibility Information for PAR-20-220, Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C-Clinical Trial Not Allowed)
Notice Number:
NOT-DK-20-038

Key Dates

Release Date:

July 8, 2020

Related Announcements

PAR-20-220 - Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C-Clinical Trial Not Allowed)

Issued by

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

The purpose of this Notice is to inform interested applicants of a change to the receipt dates for PAR-20-220 "Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C-Clinical Trial Not Allowed)", and to provide further clarification on eligibility within Metropolitan Statistical Areas (MSAs). Specifically, the September 28, 2020, September 28, 2021, and September 28, 2022 receipt dates have been changed to October 14, 2020, October 14, 2021, and October 14, 2022. Additional information on how MSAs are defined is also provided below. Changes are shown below in bold italics.

Part 1. Overview Information, Key Dates section has been modified as follows to change the application due dates, open date and expiration date of this FOA:

Currently Reads:

Open Date (Earliest Submission Date)

August 28, 2020

Application Due Date(s):

September 28, 2020, September 28, 2021, September 28, 2022

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Letter of Intent Due Date(s)

30 days prior to the application due date

AIDS Application Due Date(s)

Not Applicable

Scientific Merit Review

February/March, 2021; February/March 2022; and February/March 2023

Advisory Council Review

May, 2021; May, 2022; May, 2023

Earliest Start Date

July 2021; July 2022; July 2023

Expiration Date

September 29, 2022

Due Dates for E.O. 12372

Not Applicable

Modified to Read:

Open Date (Earliest Submission Date)

September 14, 2020

Letter of Intent Due Date(s)

30 days prior to the application due date

Application Due Date(s):

October 14, 2020, October 14, 2021, and October 14, 2022

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

Scientific Merit Review

February/March, 2021; February/March 2022; and February/March 2023

Advisory Council Review

May, 2021; May, 2022; May, 2023

Earliest Start Date

July 2021; July 2022; July 2023

Expiration Date

October 15, 2022

Due Dates for E.O. 12372

Not Applicable

Part 2., Section III. Eligibility Information, 3. Additional Information on Eligibility section has been modified to further clarify the definition of Metropolitan Statistical Areas (MSAs).

Currently Reads:

Number of Applications

Only one application per institution (normally identified by having a unique DUNS number or NIH IPF number) is allowed. A single consolidated, application from several institutions within the same Metropolitan Statistical Area, as defined by the Office of Management and Budget (MSA, https://www.whitehouse.gov/omb/information-regulatory-affairs/statistical-programs-standards) is strongly encouraged and preferred.

Modified to read:

Number of Applications

Only one application per institution (normally identified by having a unique DUNS number or NIH IPF number) is allowed. A single consolidated, application from several institutions within the same Metropolitan Statistical Area, as defined by the Office of Management and Budget (MSA, https://www.whitehouse.gov/omb/information-regulatory-affairs/statistical-programs-standards) is strongly encouraged and preferred. A MSA consists of the county or counties (or equivalent entities) associated with at least one urbanized area of at least 50,000 population, plus adjacent counties having a high degree of social and economic integration with the core as measured through commuting ties (https://www.census.gov/programs-surveys/metro-micro/about/glossary.html). To assist applicants in determining the boundaries of MSAs, please utilize the delineation files resource at the U.S. Census website (https://www.census.gov/geographies/reference-files/time-series/demo/metro-micro/delineation-files.html) or contact the NIDDK program staff listed below.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Victoria Spruance, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-827-5091
Email: victoria.spruance@nih.gov

Tracy Rankin, Ph.D., M.P.H.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-594-4748
Email:rankint@niddk.nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices